| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
SEC
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) (Salarius or the Company) cites an error on the S&P CapIQ platform and reitera...
On November 17, 2025, Salarius Pharmaceuticals, Inc. (the "Company") became aware that certain financial market data pl...